Symptoms reported by patients with varying stages of glaucoma: Review of 401 cases

Lamoureux, 2007, The Impact of Vision Impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and Rasch analysis, Invest Ophthalmol Vis Sci, 48, 1001, 10.1167/iovs.06-0361 Lee, 1998, The Glaucoma Symptom Scale: a brief index of glaucoma-specific symptoms, Arch Ophthalmol, 116, 861, 10.1001/archopht.116.7.861 Kulkarni, 2012, Visual field staging systems in glaucoma and the activities of daily living, Am J Ophthalmol, 154, e443 Mangione, 2001, National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire, Arch Ophthalmol, 119, 1050, 10.1001/archopht.119.7.1050 Jampel, 2001, Glaucoma patients’ assessment of their visual function and quality of life, Trans Am Ophthalmol Soc, 99, 301 Spaeth, 2006, Evaluation of quality of life for patients with glaucoma, Am J Ophthalmol, 141, S3, 10.1016/j.ajo.2005.07.075 Lamoureux, 2007, Are standard instruments valid for the assessment of quality of life and symptoms in glaucoma?, Optom Vis Sci, 84, 789, 10.1097/OPX.0b013e3181334b83 Severn, 2008, Which quality of life score is best for glaucoma patients and why?, BMC Ophthalmol, 8, 2, 10.1186/1471-2415-8-2 Khadka J, McAlinden C, Craig JE, Fenwick EK, Lamoureux EL, Pesudovs K. Identifying content for the Glaucoma-specific Item Bank to Measure Quality-of-life Parameters [published online April 2, 2013]. J Glaucoma. Ramakrishnan, 2003, Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey, Ophthalmology, 110, 1484, 10.1016/S0161-6420(03)00564-5 Jacob, 1998, Prevalence of primary glaucoma in an urban south Indian population, Indian J Ophthalmol, 46, 81 Lee, 2005, Glaucoma and its treatment: a review, Am J Health Syst Pharm, 62, 691, 10.1093/ajhp/62.7.691 Nelson, 2003, Quality of life in glaucoma and its relationship with visual function, J Glaucoma, 12, 139, 10.1097/00061198-200304000-00009 Noe, 2003, Associations between glaucomatous visual field loss and participation in activities of daily living, Clin Experiment Ophthalmol, 31, 482, 10.1046/j.1442-9071.2003.00712.x Gutierrez, 1997, Influence of glaucomatous visual field loss on health-related quality of life, Arch Ophthalmol, 115, 777, 10.1001/archopht.1997.01100150779014 Zeyen, 1995, Formulas for conversion between Octopus and Humphrey threshold values and indices, Graefes Arch Clin Exp Ophthalmol, 233, 627, 10.1007/BF00185283 Leung, 2008, Prevalence of ocular surface disease in glaucoma patients, J Glaucoma, 17, 350, 10.1097/IJG.0b013e31815c5f4f Rossi, 2009, Dry eye syndrome-related quality of life in glaucoma patients, Eur J Ophthalmol, 19, 572, 10.1177/112067210901900409 Fechtner, 2010, Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications, Cornea, 29, 618, 10.1097/ICO.0b013e3181c325b2 Skalicky, 2012, Ocular surface disease and quality of life in patients with glaucoma, Am J Ophthalmol, 153, e2 Abegão Pinto L, Vandewalle E, Gerlier L, Stalmans I; CosoptUD Switch Study Group. Improvement in glaucoma patient quality of life by therapy switch to preservative-free timolol/dorzolamide fixed combination [published online December 21, 2013]. Ophthalmologica. 2014;231:166-171. Stalmans, 2013, Preservative-free treatment in glaucoma: who, when, and why, Eur J Ophthalmol, 23, 518, 10.5301/ejo.5000270 Janz, 2001, The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma, Ophthalmology, 108, 1954, 10.1016/S0161-6420(01)00874-0 Guedes, 2013, Quality of life of medically versus surgically treated glaucoma patients, J Glaucoma, 22, 369, 10.1097/IJG.0b013e31824ceb8b Cohen, 1988